Historique
Rapport
EMCDDA-Europol joint report on a new psychoactive substance: 5-(2-aminopropyl)indole : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances
Auteur(s) :
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction) ;
Europol
Année
2013
Page(s) :
36 p.
Langue(s) :
Anglais
Collection :
Joint reports
ISBN :
978-92-9168-596-7
Refs biblio. :
13
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus mots-clés
PHENOMENE EMERGENT
;
DROGUES DE SYNTHESE
;
SAISIE
;
ANALYSE CHIMIQUE
;
INTOXICATION
;
FACTEUR DE RISQUE
;
MORTALITE
;
CONTROLE DES STUPEFIANTS
Thésaurus géographique
EUROPE
Organismes
OEDT
Note de contenu :
TABLE OF CONTENTS:
Introduction
Information collection process
Information required by Article 5.2 of the Decision
Information from the EMA as requested by Article 5.3 of the Decision
Summary of findings
Conclusions
Annexes:
Annex 1 - Main information sources
Annex 2 - Details of seizures and collected samples of 5-(2-aminopropyl)indole (5-IT) reported to the EMCDDA
Annex 3 - Deaths associated with 5-(2-aminopropyl)indole (5-IT) reported to the EMCDDA
Introduction
Information collection process
Information required by Article 5.2 of the Decision
Information from the EMA as requested by Article 5.3 of the Decision
Summary of findings
Conclusions
Annexes:
Annex 1 - Main information sources
Annex 2 - Details of seizures and collected samples of 5-(2-aminopropyl)indole (5-IT) reported to the EMCDDA
Annex 3 - Deaths associated with 5-(2-aminopropyl)indole (5-IT) reported to the EMCDDA
Résumé :
At the end of September 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance 5-(2-aminopropyl)indole (commonly known by the abbreviation '5-IT'), through a joint assessment. The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on 5-(2-aminopropyl)indole as stipulated by Article 5.1 of the Council Decision 2005/387/JHA.